A three-year-old boy was admitted to the hospital with a three-day history of chickenpox and a oneday history of fever and enlarging skin lesions on his chest, trunk, and around his neck. The lesions were enlarged and skin peeling over the chest wall was noted. Despite starting him on Flucloxacillin/Aciclovir, new lesions were noted with blisters over chest, legs, arms and buttocks. A clinical diagnosis of Staphylococcal Scalded Skin Syndrome (SSSS) was made and laboratory results confirmed Methicillin sensitive Staphylococcus aureus (MRSA) isolation. The isolates were sent to Scottish MRSA reference lab (SMRSARL) for typing and toxin detection. The isolate from this child was positive for the exfoliative toxin A (eta) gene and negative for exfoliative toxin B, toxic shock syndrome toxin, panton-valentine leukocidin and entertoxins A, B, C, D, E. By Pulse Field Gel Electrophoresis (PFGE) this isolate was identified as MLST Type 88 clone which has been associated with skin lesions in other countries.
Aims Establish how national Long Term Follow Up recommendations can be implemented locally in a paediatric department of a large general hospital. Establish the number of patients who currently have an end of treatment summary in their notes. Determine how many patients are attending appointments. Identify if the appropriate patients are attending clinics. Methods The medical notes for all patients appointed to attend the long term follow up clinic over the preceding two years were reviewed (93 patients). It was noted whether each patient had an end of treatment summary present in their notes Attendance at clinic over the past two years was noted. Patients were assigned into different groups according to the ‘Therapy-based recommended levels of follow-up’.1 Abstract G179(P) Table 1 Level Treatment Follow up Frequency Examples 1 Surgery alone, Low risk Chemotherapy Postal or telephone 1–2 years Low risk Wilms’LCH (single –system)GCH (Surgery only) 2 Chemotherapy, Low dose cranial irradiation (<24 Gy) Nurse-led or primary care 1–2 years Majority of patients (eg ALL) 3 Radiotherapy (> 24 Gy) Megatherapy Medically supervised LFTU Clinic Annually Brain tumours,post BMT, Any stage 4 patients Results The majority (91%) of patients did not have an end of treatment summary in their notes. The majority of patients were in treatment ‘level 2’ (47%).Those in levels 2&3 will require long term medically supervised follow-up (nurse led or GP if level 2). Attendance at clinic was noted & of those attending clinic, those with the best ‘full time’ attendance were those deemed to be ‘level 2’ patients. Followed by level 3 and 1 respectively. Conclusion An ‘End of Treatment Summary’ should be implemented in the notes of all patients who have completed their treatment for childhood cancer. Review current attendance of those deemed to be level 2 or 3 patients with the view to implementing a postal questionnaire in order to re-engage patients currently lost to follow-up. Reference Wallace, W Blacklay, A Eiser, et al. Developing strategies for long term follow up of survivors of childhood cancer. BMJ 2001;323:271-4. Abstract G179(P) Image 1 Abstract G179(P) Image 2 Abstract G179(P) Image 3
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.